Task: Answer the multiple-choice question.
Question: Which drug has a 16.455% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a CC(C)c1[nH]nc2c1C(c1cccnc1)C(C#N)=C(N)O2
b C=CCNC(=S)Nc1ccc(C(N)=O)cc1
c C/C(=N/NC(=O)c1ccc2c(c1)OCO2)c1ccc(Br)s1
d CCOC(=O)c1csc(NC(=O)C2=COCCO2)n1
Answer: d. CCOC(=O)c1csc(NC(=O)C2=COCCO2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOC(=O)c1csc(NC(=O)C2=COCCO2)n1
CCOC(=O)c1csc(NC(=O)C2=COCCO2)n1
ethyl 2-(2,3-dihydro-1,4-dioxine-5-carbonylamino)-1,3-thiazole-4-carboxylate